Evergrande Health Industry Group Limited provided earnings guidance for the six months ended 30 June 2019. The Group is expected to record a net loss for the six months ended 30 June 2019 of approximately RMB 2 billion, whereas the net profit of the Group for the six months ended 30 June 2018 was approximately RMB 200 million. The Group expects that the net loss recorded in the first half of 2019 is primarily attributable to the development of the new energy vehicle business, which is in its early investment stage and resulted in an increase in research and development and other related costs and interest payments. The new energy vehicle business of the Group is expected to record a net loss for the first half of 2019 of approximately RMB 2 billion. The development of the health management segment of the Group remained stable during the same period.